Comparison of the effect of ropivacaine and ketamine on pain control after cholecystectomy

Comparison of the effect of intraperitoneal ropivacaine and ketamine on pain control after cholecystectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220411054499N1

Enrollment

120

Registered

2022-05-24

Start date

2022-05-24

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis. Cholecystitis

Interventions

Intervention 1: Intervention group: Injection of 0.5 mg / kg intraperitoneal Ketamine diluted in 30 ml of normal saline, which will be injected into the liver space at the end of the operation before

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18-60 years old Patients indicated for laparoscopic cholecystectomy All patients with a VAS score equal or greater than 5

Exclusion criteria

Exclusion criteria: Hypersensitivity to Ketamine or Ropivacaine Has cardiovascular, lung or mental illness Arbitrary use of any additional painkillers after surgery Patients indicated for open cholecystectomy

Design outcomes

Primary

Measure	Time frame
Patients' pain based on visual analog scale. Timepoint: 2, 4, 8, 12, 24 hours after surgery. Method of measurement: Use visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Reza Naeimi

Arak University of Medical Sciences

amirrezanaeimi@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026